AKT1 and colorectal cancer: In the context of glucose metabolism, ANGPTL4 modulates the expression of glucose transporters in colorectal cancer by activating the phosphatidylinositol 3-kinase (PI3K)-protein kinase B (Akt) signaling pathway, thereby promoting glucose metabolism [54].